Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
Clinical trial NCT03292848 · COMPLETED
Trial details
- NCT number
- NCT03292848
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-10
- Primary completion
- 2018-05-21
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.